Taxanes: The genetic toxicity of paclitaxel and docetaxel in somatic cells of Drosophila melanogaster

Mutagenesis

Volumn 16, Issue 1, 2001, Pages 79-84

  Cunha, Kênya Silva ^a   Reguly, Maria Luíza ^b   Graf, Ulrich ^c   Rodrigues De Andrade, Heloisa Helena ^b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYTOCHROME P450; DOCETAXEL; LIGAND; PACLITAXEL; TAXANE DERIVATIVE; VINCRISTINE SULFATE;

ANALYTIC METHOD; ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; DRUG ACTIVATION; DRUG DETOXIFICATION; DRUG STRUCTURE; DRUG TRANSFORMATION; ENZYME MECHANISM; GENOTOXICITY; MICROTUBULE ASSEMBLY; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL; SOMATIC CROSSING OVER; SOMATIC MUTATION;

ANIMALIA; DROSOPHILA MELANOGASTER; MELANOGASTER;

EID: 0035166528     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/16.1.79     Document Type: Article

References (37)

1. Cytochrome P450 hPCN3, a novel cytochrome P450 IIIA gene product that is differentially expressed in adult human liver
2. Recombinagenic activity of integerrimine, a pyrrolizidine alkaloid from Senecio brasiliensis, in somatic cells of Drosophila melanogaster
3. Taxol (paclitaxel), première molécule d'une nouvelle classe d'agent cytotoxiques: Les taxanes
4. Taxol metabolism by human liver microsomes: Identification of cytochrome P450 isozymes involved in its biotransformation
5. Mutagenic properties of anticancer drugs
6. Statistical methods to decide whether mutagenicity test data from Drosophila assays indicate a positive, negative or inconclusive result
7. Optimal experimental design and sample size for the statistical evaluation of data from somatic mutation and recombination tests (SMART) in Drosophila
8. Induction of somatic mutation and recombination by four inhibitors of eukaryotic topoisomerases assayed in the wing spot test of Drosophila melanogaster
9. New tester strains with improved bioactivation capacity for the Drosophila wing spot test
10. Drosophila wing-spot test: Improved detectability of genotoxicity of polycyclic aromatic hydrocarbons
11. Genotoxicity of ethyl carbamate in the Drosophila wing spot test: Dependence on genotype-controlled metabolic capacity
12. The taxoids: Paclitaxel and docetaxel
13. Comparison of the aneugenic effect of vinorelbine and vincristine in cultured human lymphocytes
14. Improved high bioactivation cross for the wing somatic mutation and recombination test in Drosophila melanogaster
15. Somatic mutation and recombination test in Drosophila melanogaster
16. Quantitative and qualitative studies of micronucleus induction in mouse erythrocytes using flow cytometry. II. Analysis of micronuclei of aneugenic and clastogenic origin by dual-colour FISH on populations of bone marrow PCEs flow sorted o
17. Quantitative and qualitative studies of micronucleus induction in mouse erythrocytes using flow cytometry. I. Measurement of micronucleus induction in peripheral blood polychromatic erythrocytes by chemicals with known and suspected genoto
18. Drosophila melanogaster somatic mutation and recombination test as a biomonitor
19. Metabolism of taxol by human hepatic microsomes and liver slices: Participation of cytochrome P450 3A4 and an unknown P450 enzyme
20. A novel form of mouse cytochrome-P450 3A(cyp 3A-16). Its cDNA cloning and expression in fetal liver
21. Microtubules and actin filaments: Dynamic targets for cancer chemotherapy
22. Taxol-induced polymerization of purified tubulin
23. Hepatic biotransformation of docetaxel (taxotere) in vitro: Involvement of the CYP3A subfamily in humans
24. Selective biotransformation of taxol to 6α-hydroxytaxol by human cytochrome P450 2C8
25. Studies with RP 56976 (taxotere): A semisynthetic analogue of taxol
26. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents
27. Metabolism of docetaxel by human cytochromes P450: Interactions with paclitaxel and other antineoplasic drugs
28. Insights from model systems. Understanding human cancer in a fly
29. Metabolism of promutagens catalyzed by Drosophila melanogaster CYP6A2 enzyme in Saccharomyces cerevisiae
30. Chromosome aberrations in mouse bone marrow cells following treatment in vivo with vinblastine and colcemid
31. Variability in human cytochrome P450 paclitaxel metabolism
32. Genetic toxicity and potential carcinogenicity of taxol
33. The results of assays in Drosophila as indicators of exposure to carcinogens
34. Performance of 181 chemicals in a Drosophila assay predominantly monitoring interchromosomal mitotic recombination
35. The taxoids: Same roots, different drugs
36. Chloral hydrate is recombinogenic in the wing spot test in Drosophila melanogaster